Copy
Better Health through Better Decisions
View this email in your browser

Editor's Letter

by Dana Alden, PhD
Spring greetings to all of you! 

Forgive me for repeating this message, but I’d like to again let all SMDM members know that there are many ways you can contribute to your Newsletter. 
Here’s the list of opportunities:    

1) Commentary – up to 350 words in length with a focus on topics that our SMDM membership will helpful to their growth as researchers, educators, clinicians, and policymakers. This is a great way to share your insights, observations, and thoughts about a topic that is important to you. And, for those who are new to the Society, a commentary piece with your very own photo and byline will go a long way toward helping you make connections with others in our organization who share your interests. 

2) News about You - What you’re “working on,” what you’ve published or presented, career positions that are open in your institution or elsewhere – another great way to make connections. 

3) Any other news you think SMDM members would find interesting, for example, Interest Group plans for the year and/or upcoming meetings, member updates, and job postings.

We are very writer-friendly and will assist in any way we can to help develop articles that contribute to the Society. If you have a Commentary article or any other contribution, please send me an email (dalden@hawaii.edu) and I’ll get right back to you.  

In this edition of  the Newsletter, SMDM President Mark Helfand emphasizes the importance of building stronger connections with policymakers, health organizations, and consumers in order to more effectively disseminate cutting edge innovations developed by members of our Society Next, there are several interesting Commentaries. John Friend looks at the advanced directive challenge in Japan and many other countries with aging populations outside of North America and Europe. Adam Skelton provides an overview of the CDCs successful internship program which has contributed to the success of many leading scholars in SMDM. Mark Liebow offers a summary of US Congressional actions that could affect healthcare practice and research in the U.S.  And, Fernando Alerid describes a very important initiative to develop open source software that is applicable in health care research and management. 

Member updates and announcements follow, including a recap of the successful 2nd biennial Asia Pacific SMDM Conference by Kat Tsang and a description of the exciting, upcoming 16th Biennial European SMDM Conference in London by Olga Kostopoulou.

We hope you'll enjoy this Spring edition of your SMDM Newsletter. As always, please feel free to email me with ideas, suggestions, or questions.

Cheers, Dana


FROM THE PRESIDENT
 

COMMENTARY
 
 
Applied Economics and Decision Sciences at the US Centers for Disease Control and Prevention, by Adam Skelton

MEMBER NEWS
Welcome Emeritus Members
Member News
What Are You Working On?
Job Postings
Lifetime Contributors
 

MEETINGS
European Conference
North American Meeting
Asia-Pacific Conference

EVENTS AND OPPORTUNITIES
Stay connected by taking advantage of these opportunities SMDM has to offer.
Join or Renew Your Membership
SMDM Connect
Opportunities to Network
Job Postings
Support SMDM
Call for Abstracts North American Meeting
Join SMDM on Facebook
Contact Us

From the President: Make our Work More Timely and Relevant to Decision-makers? When? How?


by Mark Helfand, MD, MPH, Portland Veterans Affairs Medical Center and Oregon Health & Science University
 

In my last column, I wrote about the need to make our work more timely and relevant for decision-makers, or known to a broader audience. I said I’m often asked when and how we are going to make our work more timely and relevant for decision-makers, or known to a broader audience. I admitted I wasn’t sure about when or how, but promised I would take up the question in this newsletter.

Exploration of ideas and techniques that sets the stage for practical applications is one of SMDM’s core strengths. This means that we help investigators improve ideas and techniques that aren’t yet ready to be applied by decision-makers. On our web page, we say our work is …”to develop and promote the use of systematic methods to deal with the uncertainties of health care decisions.” More precisely, that is our members’ work. Our work as a Society is to help them create, develop and refine these methods.  

We’ve been very successful in this work. Much of what is now usual in the clinical and policy worlds can be traced to ideas and innovations from members of SMDM. In this sense, SMDM is highly influential, but indirectly so. When SMDM plays an important role in a member’s professional life, or played a role along their way, credit goes, first, to them, and to their institution, and the organizations they work with or influenced. This is appropriate, but it means that SMDM’s name or role may not be as widely recognized as it might be.

Some of the work presented at our meetings and in our journals is timely and relevant to decision makers. When it is, we don’t do enough to get the word out. That problem was on my mind constantly when I was editor of Medical Decision Making. I felt we weren’t doing enough to bring attention to the work presented at our meetings and in the journal.  

There is the question of whether we are listening to decision-makers in the first place. Are we addressing problems that are important to them now? I think we are, but we aren’t as likely to address their immediate concerns as we are to anticipate future ones. I don’t think it is always the best thing to be chasing down the immediate problems of policymakers, clinical leaders, and other decision-makers. But we should be in touch with, and listen to the subset of them who are true leaders, that is, who are thinking about problems that we will face or that we could solve five or ten years from now.

In this regard, we should consider playing a defined role in initiatives that are related to our expertise and mission as a society. With very few exceptions, SMDM has not become involved with such initiatives directly. For example, Choosing Wisely, the American Board of Internal Medicine Foundation’s initiative to get people to talk and think about overuse of health care resources, lists about 65 organizations and about 25 consumer organizations as partners. The Society for Healthcare Epidemiology of America and Wikipedia are on the list, but not us. We provide a forum for interdisciplinary scholarship and methodological growth, but we usually haven’t, as a society, started or joined initiatives to tackle the uncertainties of health care decisions or improve decision making. As an organization, not just as individuals, we need to find and work with leaders in government, industry, health care systems, consumer and patient advocacy, and other sectors, and, often, the formative stages of these initiatives are where they live.
 
 

The opinions stated in the following commentaries are solely those of the authors and do not reflect the opinions of the Society for Medical Decision Making.

 

Death and Dying in Japan: Shared Decision Making and Advance Care Planning Challenges 


by John Friend, PhD

End-of-life care poses a special problem for shared decision making (SDM). Take for example the wide range of preferences and values associated with advance care planning that can either serve as barriers or facilitators to effective patient-physician communication. Failure to account for the cultural values that shape what patients and families believe to be appropriate during end-of-life can result in unwanted aggressive care, costly procedures, and caregiver bereavement difficulties. To improve the quality of palliative care and promote SDM, advance directives and living wills have been used to help patients determine the type of end-of-life medical treatment they prefer such as the use, or discontinuation, of life-sustaining technologies.

In some countries like Japan, however, end-of-life care is only starting to receive more attention. As Japan’s population of people over seventy-five years old is expected to double between 2005 and 2030, hospitals and health care providers in the country are becoming increasingly more concerned about improving end-of-life care systems, educating both physicians and the public on advance care planning, and establishing guideline-based management. Numerous studies suggest that uptake will not be easy as the term advance care planning is not very popular with patients and physicians and a sizable portion of the Japanese population does not have advance directives in place. In fact, previous research revealed that only 0.6% of the Japanese population in 2003 had living wills and 2.6% of Japanese between the ages of 40 and 65 had written treatment preferences in 2004. Such low rates highlight a significant obstacle for health care providers in Japan. Not only does end-of-life decision making involve selecting medical therapies but also, in some instances, determining a health care proxy, locus of care, and coping decisions. Interestingly, Japan is not the only society facing advance care planning challenges. For example, like Japan, older adults in South Korea appear to have limited knowledge of and experience with advance directives, lack of community awareness about palliative care in many Middle Eastern countries is a concern, and advance care planning remains uncommon in Australia.
  
In response to the low rates of advance directives in Japan and other societies, improving the patient-physician relationship toward patient-centered palliative care appears to be an important next step. In particular, additional research on factors affecting patients’ attitudes toward advance directives and preferences for life-sustaining treatments is needed. For example, what roles do cultural antecedents such as independent and interdependent self-construal play in end-of-life decision making. Previous research has found that many Japanese patients prefer family-centered decision making. However, does this desire for family involvement carry over to advance care planning? If so, how much family involvement? 

To begin answering these questions, researchers from Japan and the U.S. are pilot testing an advance care planning decision aid for tube feeding in Japan and measuring its effect on participants’ knowledge and decision confidence and preparedness. Recognizing cultural differences shape the ways in which advance directives are undertaken, this project seeks to better understand core value influences on end-of-life decision making in Japan. The research team invites collaborators from other countries to consider joining the project. For more information, please email: jfriend@csbsju.edu.

Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

The opinions stated in the following commentary are solely those of the authors and do not reflect the opinions of the Society for Medical Decision Making.


 

Health Decision Sciences in the Era of Open-source Software 


by Fernando Alarid-Escudero on behalf of the Decision Analysis in R for Technologies in Health (DARTH) workgroup 

There’s no doubt we are in the era of Open-Source Software (OSS), but how much has OSS infiltrated into health decision sciences? A quick search in Wikipedia for “open-source programming language licensing” yielded a list of 80 programs, such as R, Python and Haskell, among others. But what exactly does open-source software mean? According to the Open Source Initiative, “An open-source software can be freely accessed, used, changed, and shared (in modified or unmodified form) by anyone.” 

OSS has gained significant popularity across many academic disciplines such as statistics and engineering. There have been significant developments and exhibitions of the use of OSS in Health Decision Sciences, but certainly not enough. Some of the most popular models used in Health Decision Sciences are being implemented in either domain-specific or proprietary software. There are many advantages to this approach, but there are also significant drawbacks. For example, if there is interest in replicating an analysis conducted using a licensed software package, individuals are constrained by not having access to the software. This could be problematic in financially constrained environments, such as academic fields where financial resources devoted to software are limited. The higher the entry costs, particularly financial costs, the less likely decision-analytic tools will become available and understood by a broader audience – an outcome that could threaten reproducibility and verifiability of the analyses. For example, in developing countries the cost of an academic or student license still represents a significant burden that most students cannot afford.

OSS expands access by reducing the financial cost. Now, OSS does not come as a free lunch as a deeper understanding is often required due to their general-purpose design. For example, graphical user interfaces (GUIs) are either non existent or not as common. This imposes a steeper learning curve compared to domain-specific software, which represents an additional entry cost. 

At SMDM’s 37th Annual North American Meeting in St. Louis, MO, USA, a group of researchers and students got together to discuss these issues. From our conversations, we decided to create the Decision Analysis in R for Technologies in Health (DARTH) workgroup. The group is an international endeavor comprised of members with shared interests and a significant experience modeling in OSS from the University of Minnesota, the University of Pittsburgh, The Hospital for Sick Children, University of Toronto, and Erasmus University of Rotterdam. As part of DARTH’s agenda, we are developing a series of documents on the use of OSS in Health Decision Sciences and tutorials on how to implement decision-analytic models using an OSS platform, specifically in R programming language. As part of this effort, we will offer courses at SMDM and other research venues. In addition, we will release a scoping review article in the near future of the use of R in Health Decision Sciences. We are in the process of developing different tutorials on how to implement comprehensive stages of the modeling process such as model building, sensitivity analysis, calibration, and value of information, among others. So stay tuned!

Our goal is to reduce the entry cost due to steep learning curves and to allow users to access advanced methods available by leveraging the advantages of OSS statistical and programming frameworks. We hope to reduce the financial and practical burden of model development and make decision-analytic modeling available to a broader audience. For more information, please feel free to contact me: alari006@umn.edu
 
 1  "Brief Definition of Open Source Licenses". Open Source Initiative. Retrieved March 06, 2016.
 
The members of the workgroup are Eva Enns, PhD, from University of Minnesota, Hawre Jalal, PhD, from University of Pittsburgh, Petros Pechnivaloglou, PhD, from SickKids at Toronto, Eline Krijkamp, MS, and Myriam Hunink, PhD, MD, from Erasmus University at Rotterdam. 

Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

The opinions stated in the following commentary are solely those of the authors and do not reflect the opinions of the Society for Medical Decision Making.


 

U.S. Health Policy has been Changing - Mostly for the Better


by Mark Liebow, MD

In the last year, important changes have occurred in U.S. health policy. A year ago, Congress passed the Medicare Access and CHIP Reauthorization Act (MACRA), which, by removing the Sustainable Growth Rate formula, eliminated the scary (if unlikely) risk of deep cuts in Medicare fees. The price paid for that was there will be minimal or no annual growth in Medicare fees over the next decade, so Medicare fees will continue to decline in real dollars. Perhaps more importantly, physicians who want to earn additional payments from Medicare, will need to participate in one of two tracks, a modified pay-for-performance track or an alternative payment model track. The latter usually involves accepting financial risk based on quality and efficiency of care provided. This may provide opportunities for modelers as there may be demand for decision and cost-effectiveness analysis by plans that accept risk. 

Seven months later, Congress passed the Bipartisan Budget Act of 2015, which raised budget caps, severely constrained by the sequestration changes that started in 2011, by $56 billion a year for two years. These increases were evenly split between non-defense and defense programs. NIH, AHRQ, and most other research agencies are funded by annual appropriations covered by the non-defense programs caps, so this meant more money was available for them. In December, the NIH got $32.1 billion in the omnibus appropriations bill, a $2 billion increase and the largest percentage increase in 12 years. The National Science Foundation got an extra $119 million, up to $7.5 billion. AHRQ only got an extra $14 million, but getting an increase is a miracle considering the House wanted to kill it and the Senate wanted to cut it by 35%. We don't expect to see appropriation bills, especially for health research agencies, before the November election.

Republicans continue to try to repeal the Affordable Care Act, which would kill PCORI. They are making more progress now that the Senate is controlled by Republicans, but President Obama vetoed the one repeal bill that made it to the White House and promises to repeal any bill repealing “Obamacare.”

Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

The opinions stated in the following commentary are solely those of the authors and do not reflect the opinions of the Society for Medical Decision Making.


 

Applied Economics and Decision Sciences at the US Centers for Disease Control and Prevention


by Adam Skelton, PhD

The Steven M. Teutsch Prevention Effectiveness (PE) Fellowship (www.cdc.gov/pef) was started in 1995 as a two-year postdoctoral research fellowship focusing on the application of quantitative methods to the science of health protection, health promotion, and disease prevention.  The PE Fellowship addresses an on-going demand in the field of public health for quantitative policy analysis, health economics-based inquiry, and integrative health services research.

The PE fellowship is currently the largest post-doctoral training program in economics and decision sciences in the US.  It is highly competitive and has graduated 133 fellows to date, over half of whom currently work at CDC.  This has helped the CDC create enviable capacity in economics and decision – the CDC employs more economists and decision scientists than any OpDiv in the DHHS.

Most PE Fellows hold doctoral degrees in economics, policy analysis, operations research or industrial engineering, health services research, or a related quantitative discipline.  Recently, the fellowship has engaged a balanced mix of economists and non-economists.


The PE Fellowship sponsors a didactic training component focusing on applied economic and decision analysis, policy analysis and communication, budget and regulatory impact analysis, health impact analysis, and leadership.  Instructors are the leaders in their respective fields.  The fellowship also hosts an entertaining and informative seminar series.

Fellowship alumni have made substantial contributions to the field, authoring an estimated 3,700 peer reviewed articles between 1997 and 2015.  Fellowship alumni at CDC have authored 155 publications in 2015 alone.  PE fellows and alumni have recently developed influential decision models around the Ebola outbreak, influenza, diabetes interventions, smoking cessation programs, cancer screening programs, HIV interventions, and immunization programs.

For more information about the PE Fellowship, please contact Adam G. Skelton, PhD, MPH, askelton@cdc.gov, 404-861-3882.

Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 




SMDM meetings provide a highly interactive forum for discussion of novel research based on decision and behavior theory and analytical models applied to health related decisions. Presentations of original research, keynote talks, special symposia and short courses offer attendees the opportunity to explore diverse topics in medical decision making and the unique ability to connect with colleagues one to one. We hope to see you there!
 

Highlights of the Upcoming SMDM 16th Biennial European Conference in London: Registration is Now Open!


by Olga Kostopoulou, Conference Chair

Register Now!This year’s SMDM 16th Biennial European Conference in London is shaping up to be an exciting event! The Conference features two keynote speakers (Professor Ralph Hertwig, ARC Director, Max Planck Institute for Human Development - "Beyond Nudging: How to Boost Medical Decision Making", and Professor Mark Graber, President, Society to Improve Diagnosis in Medicine - “Diagnosis - The Ultimate Test of Medical Decision Making;"); two invited symposia (vaccination decision making and cancer diagnosis); and a packed programme of high quality short courses by SMDM experts, oral and poster presentations. 

The Conference will be held in historic central London (https://30eustonsquare.co.uk/), well-connected for public transport and close to major cultural sites (the Wellcome Collection, the British Library, the British Museum), entertainment areas (the Granary Square), fashion for all tastes (Camden Town, Marylebone, Oxford Street), and nature (Regent’s Park). 

Hotel reservations are now open at two hotels, both within a few minutes walk from the conference site: http://smdm.org/meeting/page/2016-london-hotel-information/16th-biennial-european-meeting
 
We are starting with short courses and a welcome reception on Sunday, June 12. Our conference dinner is on Monday, June 13, and we hope for a nice summer’s day, as we are having drinks on the roof terrace at 30 Euston Square beforehand. The conference will finish on Tuesday afternoon.  

For more information on the programme and hotel/travel bookings, go to http://smdm.org/meeting/16th-biennial-european-meeting

Anne, Liz, and I hope to see you in London in June!



Chair: Olga Kostopoulou, PhD, MSc, Imperial College London
Co-chairs: Anne Stiggelbout, PhD, Leiden University Medical Center, and Elisabeth Fenwick, PhD, MSc, ICON Health Economics


Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

38th Annual North American Meeting Call for Abstracts and Short Courses Deadline: May 31, 2016


SMDM is now accepting abstracts for Oral and Poster Sessions and proposals for Short Courses to be presented at its 38th Annual North American Meeting. The deadline to submit proposals is Tuesday, May 31, 2016. All submissions will be reviewed and notifications sent out in early August 2016. Click here for more information 

This year's annual meeting will be held October 23 - October 26, 2016, at the Westin Bayshore, in Vancouver, BC, Canada. The theme of this year's meeting is From Uncertainty to Action. As Ellen Peters wrote, “uncertainty abounds” in health care decisions. From decision models to decision aids and prediction tools, incorporating and communicating uncertain information is key to transparent, informed decision-making for individuals, clinicians, and policy makers. For over 30 years, SMDM members have sought to improve decision-making while accounting for uncertainty about the magnitude and severity of benefits and risks, the strength of current evidence, and how to weigh risks and benefits from the perspectives of the individual, health system, and society. The 38th annual SMDM meeting offers researchers, clinicians, and provincial, state, and national health authorities the opportunity to exchange insights, tools, and new challenges in moving from uncertainty to action. 

Co-chairs: Mark Helfand, MD, MPH, and Nick Bansback, PhD


Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

Reflecting on the SMDM 2nd Biennial Asia-Pacific Conference 


by Katrina Tsang, Meeting Chair

The 2nd Biennial Asia-Pacific SMDM Conference was successfully held at The Chinese University of Hong Kong on January 8-10, 2016. The theme of the Conference was, "Making Difficult Clinical and Policy Decisions: The Example of Ageing and End of Life Care in Asia-Pacific".

Over 60 attendees joined the six pre-conference short courses, many of whom were new to SMDM and subsequently joined to become members. There was even one attendee who had a life changing moment and shared that he would switch his research direction to focus on MDM!

More than 130 delegates from over 20 countries participated in the main conference. The opening ceremony was attended by Prof FOK T. F., Pro-Vice Chancellor of The Chinese University of Hong Kong and representatives from supporting organisations: CUHK Jockey Club Institute of Ageing, Hong Kong College of Family Physicians, Hong Kong Academy of Medicine and CUHK Centre for Bioethics. Dr. Iona Heath, former president of the Royal College of General Practitioners and British Medical Journal columnist, delivered a thoughtful and timely keynote speech on “The Importance of Uncertainty.,” Dr. Heath’s talk focused on the uncertainty that “exists in the gap between the territory of human suffering and the map of biomedical science”.

The plenary session on individual-level decision making was chaired by Professor Jean Woo (Emeritus Professor of Medicine, Chairman of Department of Medicine and Therapeutics, Head of Division of Geriatrics, and Directors for S.H. Ho Centre for Gerontology and Geriatrics, and Institute of Aging), with the following panellists joining the discussion: Dr Noreen Chan (Senior Consultant in Palliative Medicine, Department of Haematology-Oncology, National University Cancer Institute, Singapore), Dr Amy Chow (Associate Professor, Dept. of Social Work & Social Administration, The University of Hong Kong), and Dr Jenny Lee (Geriatrics Consultant, Alice Ho Miu Ling Nethersole Hospital, Hong Kong). The discussion delved deeper into the realities of high levels uncertainty in decision making in EOL and ageing; the challenges, barriers and successes of SDM using real scenarios the speakers encountered in their work. Congratulations to the recipients of the SMDM Young Scientist Asia-Pacific Award: Dr Kiatpongsan Sorapop for his research conducted in Thailand and Fan YANG for her research in Singapore!

I am deeply grateful to all of you who came to the conference and worked so hard to make this possible! A working group based in Asia-Pacific has been formed to promote MDM and SMDM in this region. Expect to hear more from this group soon!










 
Photos by Ms. Amelia Yung

Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home

 

Welcome Emeritus Members 


The Board of Trustees has approved the following members for Emeritus Status:

Helmut Wenzel, MAS, Retired, Konstanz, Germany.

Theodore Speroff, PhD, GRECC/HSR VA TVHCS, Vanderbilt University Medical Center, Nashville, TN

The Emeritus classification is awarded by a majority vote of the Board. Click here to learn more about Emeritus Membership in SMDM.


Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

Members in the News


Muge Capan, PhD, reports that their study on Neonatal Intensive Care Unit census forecasting entitled "Time Series Analysis for Forecasting Hospital Census: Application to the Neonatal Intensive Care Unit" was recently accepted for publication in Applied Clinical Informatics. This article presents Autoregressive Integrated Moving Average (ARIMA) and regression models - that can be easily applied in clinical practice - applied to various 7-day prediction periods and compared using error statistics. The results show that time series models provide higher prediction accuracy under different census conditions compared with the fixed average census approach to support census forecasting and resource planning.   Muge.Capan@ChristianaCare.org
 


Marieke de Vries, PhD, recently moved to Radboud University, Institute for Computing and Information Sciences (iCIS), Behavioural Science Institute (BSI), and Science Management and Innovation (Health Innovation).  M.deVries@cs.ru.nl
 


 

Nida Shahid, MSc (candidate), Toronto Health Economics and Technology Assessment Collaborative, recently co-authored “A multi-level qualitative analysis of Telehomecare in Ontario: challenges and opportunities”.  This study explores facilitators and barriers to implementation and adoption of Telehomecare across three Local Health Integration Networks in Ontario. Nida Shahid has been the project lead for the Program Evaluation of Telehomecare in patients with heart failure or chronic obstructive pulmonary disease: TeLeCare (TLC) Study and currently, the TeleHomecaRe InterVention Evaluation (THRIVE) study under the leadership of Drs. M Krahn and V Rac. In addition to being project lead to evaluation of complex interventions, Nida is enrolled in graduate studies at Faculty of Medicine, University of Toronto. nida.shahid@theta.utoronto.ca
 



Dawn Stacey, RN, PhD, received an elected membership in the Royal Society of Canada's College of New Scholars, Artists, and Scientists in November 2015. This membership recognizes that she has achieved excellence in her program of research focused on understanding, measuring, and evaluating implementation  of decision coaching and decision support tools for patients and healthcare professionals. She is a professor at the University of Ottawa and Scientific Director of the Patient Decision Aids Research Group at the Ottawa Hospital Research Institute. dstacey@uottawa.ca
 



Ebere Onukwugha, PhD, University of Maryland School of Pharmacy, served as the guest editor for a Big Data themed issue of PharmacoEconomics which has now been published (February 2016). This themed issue represents perspectives on data sources, measurement, and analysis relevant to the use of Big Data in health economics and outcomes research. This collection of papers and opinion pieces covers geographically diverse applications to highlight  perspectives on 'big data' across institutional, government and health system settings.  eonukwug@rx.umaryland.edu

 
Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

What Are You Working On?


submitted by: Lakshmi Mahadevan, PhD Scholar, IIT Bombay, India
sangee0105@gmail.com

I am working in the area of medical decision making. The primary focus of my work is to understand in detail, the process by which medical interns (who are in the final year of MBBS degree) make diagnostic decisions. The research also aims to understand the contribution of personality, cognitive style and workload in medical decision making. The samples are collected from medical interns from various medical colleges in India. 
 

We Want to Hear from You!
This section of the Newsletter invites you to describe current projects that are either in the formative stage or underway. The idea is to enable all of us to learn more about the ongoing activities of our Society and to potentially connect members with like interests on a regular basis! Please consider submitting news about projects in the idea stage as well as those that are ongoing to this section, and if you are looking for collaborators or advice in a specialized area, don’t hesitate to include that information in your submission. 

 
Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 

Job Postings


Lecturer in Medical Decision Making
Imperial College London

The Department of Surgery and Cancer at Imperial College London invites applications for a full-time tenure track position of Lecturer in Medical Decision Making (equiv. to Assistant Professor, salary range: £46,410 - £51,720 per annum). Applicants should hold a Higher degree, and PhD in a relevant area of psychology, and have significant postdoctoral experience and a developing reputation in an area related to Medical Decision Making. 

The Lecturer should be an independent investigator with:
  • A strong quantitative background, and knowledge of research design, experimental methodologies, and advanced statistics.
  • Good publication record in high impact factor journals, as appropriate for the discipline.
  • External funding and/or evidence that external funding will be obtained in due course.
  • Ability and motivation to apply methodological skills and expertise to study health-related decisions by physicians and/or patients.
  • Ability to work in a multidisciplinary environment and to discuss his/her research with non-experts in an intelligible and approachable way.
  • Vision about the direction that his/her research will take.
Closing date for applications: May 30, 2016. 

You can download a detailed job description and an application form on the College website.

For further information, e-mail Olga Kostopoulou (o.kostopoulou@imperial.ac.uk)
 

The University of Michigan Medical School invites applications and nominations for the director of the Center for Bioethics and Social Sciences in Medicine (CBSSM) (http://cbssm.med.umich.edu/).  

The CBSSM is the intellectual home at the University of Michigan for clinicians, social scientists, psychologists, bioethicists, and all others interested in improving individual and societal health through application of social science and bioethics methods to health research, education and public outreach. CBSSM attracts scholars from across departmental, school, and disciplinary boundaries, is an integrated part of the highly interdisciplinary UM Institute for Healthcare Policy and Innovation (IHPI), and is affiliated with the VA Ann Arbor Healthcare System Center for Clinical Management Research. Our community includes clinicians from a diverse range of specialties (including internal medicine, oncology, surgery, and obstetrics among many others), social and cognitive psychologists, behavioral economists, bioethicists, decision scientists, survey methodologists, sociologists, and public health researchers.

Candidates must have shown scholarly distinction in bioethics and/or social science-oriented health services research, a strong track record of developing programs, of sustained extramural funding, and of mentoring junior faculty and trainees, and a demonstrated commitment to education.  Candidates must hold an MD, PhD or equivalent doctoral degree and be eligible for tenure at the rank of associate professor or professor eligible for a faculty appointment at the University of Michigan.

Please submit your CV and cover letter electronically in one attachment to:
Courtney Godfrey (csaltz@umich.edu)
University of Michigan Medical School Office of the Dean

The University is a non-discriminatory/equal opportunity employer
 

The following positions have been recently posted in the Resource Section of SMDM Connect
  • Faculty Search - Ohio State Colleges of Public Health and Medicine
  • Assistant/Associate Member, Behavioral Economist Hutchinson Institute for Cancer Outcomes Research
  • Tufts Medical Center Post-Doctoral Fellow in Health Economics and Value Measurement
  • Director Health Services Research, Christiana Care Health System - Newark, DE
  • Director of CBSSM, University of Michigan

Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 
 

SMDM Lifetime Contributors


SMDM extends its heartfelt appreciation to members for their charitable contributions over the years!
 
Raiffa-Kahneman Circle 
(Contributions total $5,000 or more)
John Clarke ('13, '14)
Jeremy Goldhaber-Fiebert ('13, '14)
Mark Helfand (‘05, ‘07, '10, '11)
Michael Kattan ('13 - '15)
Joseph King (‘06 - '15)
James Stahl, Stahl Family/Stahl Bioethics Foundation in honor of Dr. Eva Bamberger Stahl (‘06, ‘09, '10, '12, ‘15)

Pareto Level
(Contributions total $1,000 - $4,999)
Dana Alden ('12 - ‘15)
Michael Barry (‘06 - '10)
Ahmed Bayoumi (‘06, '08 - ‘15)
Dennis Fryback (‘05 -'15)
Murray Krahn ('13, '14)
William Lawrence (‘06, '10, '11, '13, ‘15)
Jill Metcalf (‘07 - '15)
David Rovner & Margaret Holmes-Rovner (‘05 - '15)
Bruce Schackman (‘06 -'15)
Marilyn Schapira (‘07 - '12, '14 - '15)
Uwe Siebert ('11, '13, '14)
Frank Sonnenberg (‘06, ‘09)
Harold and Carol Sox ('10 - '15)
Sankey Williams (‘06 - ‘08, '13, '14)
John Wong (‘06, - '13)

Edwards Level
(Contributions total $750 - $999)
Scott Cantor & Lisa Stone (‘07 - '15) 
Neal Dawson (‘05 - '15)
Sara Knight (‘05 - '15)
David Meltzer ('07, '09)
Stephen Pauker (‘06, ‘09)
Mark Roberts (‘08, ‘09, '13, ‘15)
Seema Sonnad (‘06, ‘07, ‘09, '12 - '14)
Joel Tsevat (‘06, ‘09, '10)

Tversky Level
(Contributions total $500 - $749)
Anirban Basu ('13)
Robert Beck (‘07) 
Donald Brand ('13 - '15)
Kate Christensen (‘09)
Nananda Col (‘05 - ‘09)
Angela Fagerlin ('14 – ‘15)
Peder Halvorsen ('11 - '15)
Myriam Hunink (‘05 - '14)
Steven Kymes (‘05 - ‘09, '12, '15)
Kathryn McDonald (‘07, '09, '10, '14, ‘15)
David Paltiel ('07, '09)
Alan Schwartz (‘07, '10 - '15)
David Sugano (‘07, ’09 – '11, '13)
Jef van den Ende (’10, '14)

von Neumann-Morgenstern Level
(Contributions total $250 - $499)
Amber Barnato (‘05, ‘07, '11, '12, '14)
Dena Bravata (‘06, ’09 -  '11)
Andy Briggs ('14)
Randall Cebul (‘06, ‘08, '10)
Mark Eckman (’06, ‘09)
Elena Elkin (‘07, '14)
Arthur Elstein (‘06, ‘07, ‘09, ‘10) 
Heather Taffet Gold (‘08, '11, '14)
Don Husereau ('13)
Karen Kuntz (‘09, '11)
Miriam Kuppermann (‘06 - '10, '12, '14 - '15)
Thomas Tape ('10, '11, '14)
Robert Wigton ('10, '11, '14)

Markov Level
(Contributions total $100 - $249)
Cathy Bradley (‘07)
Scott Braithwaite (’09)
Linda Canty ('12)
Jag Chhatwal ('15)
Phaedra Corso (‘06, ‘07, ‘08)
Magdelena Flatscher-Thöni ('14)
Liz Fenwick ('14 – ‘15)
Alan Garber ('10)
Robert Hamm (‘06, ‘08, '14)
Joseph Johnston (’15)
Paal Joranger (‘14)
Esther Kaufmann ('11)
Sun-Young Kim (‘07, ‘08, ‘10, '13)
Joseph Ladapo ('12 - '15)
Curtis Langlotz ('12)
Lisa Maillart ('10)
Peter Neumann ('14 – ‘15)
Richard Orr (‘05, ‘06)
Jesse D. Ortendahl ('11, '12, '13)
Mary Politi ('14, ‘15)
Roy Poses ('14)
Brian Rittenhouse (‘07)
Ursula Rochau ('14)
Allison Rosen (‘07)
Natasha Stout ('14)
Verena Stühlinger ('14)
Joanne Sutherland (‘08, ‘09)
John Thornbury (‘05)
George Torrance (‘05)
Benjavan Upatising ('13)
Brian Zikmund-Fisher (‘08 - '15)

Bayes Level
(Contributions total up to $100)
Jessica Ancker ('14)
Hilary Bekker ('12)
Eran Bendavid ('11)
Tanya Bentley ('14)
Denise Bijlenga (‘08)
Kimberly Blake (‘09)
Cindy Bryce ('14)
Rowland Chang (‘06, ‘07)
Carmel Crock (‘09)
James Dolan (‘09)
Arna Dresser ('10, 12, '14)
Rohan D'Sousa ('15)
Ted Ganiats (‘05)
Lee Green (‘07, ‘09)
Amit Gupta (‘06)
Michael Hagen ('10)
Negin Hajizadeh ('14)
Sarah Hawley ('14)
Kristin Hendrix ('14)
David Howard (‘09)
David Katz (’08)
Job Kievit (‘09)
Kerry Kilbridge (‘05, ‘07, ‘08)
April Kimmel ('14)
Sarah Kobrin ('14)
Ivar Sonbo Kristiansen ('10)
Andrew Scott LaJoie ('10)
Clara Lee ('15)
Sarah Lillie ('14 – ‘15)
Andreas Maetzel (‘09)
Daniel Masica (‘08)
Evan Myers ('12)
Thomas B. Newman ('10)
Jane Pai ('10)
George Papadopoulos (‘08)
Lisa Prosser (‘08)
Valeria Reyna ('14)
Michael Rothberg (‘09 - '12)
Gillian Sanders (‘07)
Jha Saurabh (‘09)
Karen Sepucha ('14)
Ewout Steyerberg (‘06, ‘09, '11, '13)
Anne Stiggelbout (‘06)
Carol Stockman (‘05)
Danielle Timmermans (‘07)
Thomas Trikalinos (’15)
Hugues Vaillancourt ('11)
Erika Waters ('14)
Milton Weinstein (‘09, '11)
Robert Werner (‘08)
Holly Witteman ('14)
Eve Wittenberg ('14)
Theodore Yuo ('15)
 

Donations received Oct. 2005 – March 11, 2016.
Bolded individuals made contributions since the last report. 
Italicized individuals moved up a level of giving in 2016.
 
Like SMDM Spring Newsletter - the latest in Medical Decision Making on Facebook
Return to Home
 
Copyright © 2020 Society For Medical Decision Making, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list